# Lignocaine Nebulization for Attenuation of Intubation Stress Response

> **NCT04441073** · PHASE4 · UNKNOWN · sponsor: **Assiut University** · enrollment: 100 (estimated)

## Conditions studied

- Pressor Response

## Interventions

- **DRUG:** Lignocaine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04441073
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-24
- **Primary completion:** 2022-02-23
- **Final completion:** 2022-02-23
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04441073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04441073, "Lignocaine Nebulization for Attenuation of Intubation Stress Response". Retrieved via AI Analytics 2026-09-12 from https://api.ai-analytics.org/clinical/NCT04441073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*